Form 3 Filing for Melissa Orilall - MiNK Therapeutics, Inc.

This filing reports initial ownership of MiNK Therapeutics, Inc. (INKT) common stock by Melissa Orilall, the Principal Financial Officer. The filing indicates that Ms. Orilall, through her spouse, holds 222 shares of common stock. This is an initial disclosure of beneficial ownership, as indicated by the Form 3 filing type. The reporting period for this transaction was March 13, 2026. The signature date was April 9, 2026.